1st Patient Dosed With Investigational T-cell Therapy NEXI-002 in Phase 1/2 Trial
NexImmune has dosed the first patient participating in…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Glycostem’s oNKord Cell-based Therapy Granted FDA Orphan Drug Designation
The U.S. Food and Drug Administration (FDA) has…
Cytovia, Inserm Partnering on NK-based Immunotherapies for Myeloma
A recent collaboration between Cytovia Therapeutics and Inserm,…
NCI Awards $1.7M for Bone Therapy Research to Prevent or Delay Cancer Relapse
The National Cancer Institute (NCI) has awarded…
Stand Up to Cancer Awards $100K for Research About Precursor Multiple Myeloma
Stand Up To Cancer (SU2C) has awarded the…
Melflufen Open to Select Adults With Advanced Multiple Myeloma in US
Oncopeptides has formally opened…
